Fundz

Fundz Deep Dive

Everything you need to win Chad Swanson — in one platform.

Who to reach, what to say, and why now on Chad Swanson — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Chad Swanson — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Prothena Corporation Plc Appoints Chad Swanson As Chief Development Officer and Hideki Garren Pursues Opportunity At Another Company

PUBLIC · PRTASep 27, 2024•over 1 year ago

Position

Chief Development Officer

Company

Prothena Corporation

Chad Swanson
DublinBiotechnologyHealth CareTherapeutics

Description

Prothena Corporation plc announced the appointment of Chad Swanson, Ph.D., as Chief Development Officer, succeeding Hideki Garren, M.D., Ph.D. Hideki Garren, M.D., Ph.D., will pursue an opportunity at a large pharmaceutical company to lead a global product development division. Prothena will also initiate a search for a world-class healthcare leader as the next Chief Medical Officer.

Company Information

Company

Prothena Corporation

Location

Dublin, Dublin, Ireland

About

Prothena Corporation plc is a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise. The company is focused on advancing a promising pipeline in neurodegenerative and rare peripheral amyloid diseases, guided by patient-focused drug development.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Prothena Corporation's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.